257 related articles for article (PubMed ID: 22354545)
1. Thyroid eye disease: towards an evidence base for treatment in the 21st century.
Gillespie EF; Smith TJ; Douglas RS
Curr Neurol Neurosci Rep; 2012 Jun; 12(3):318-24. PubMed ID: 22354545
[TBL] [Abstract][Full Text] [Related]
2. Orbital Radiotherapy Combined With Corticosteroid Treatment for Thyroid Eye Disease-Compressive Optic Neuropathy.
Gold KG; Scofield S; Isaacson SR; Stewart MW; Kazim M
Ophthalmic Plast Reconstr Surg; 2018; 34(2):172-177. PubMed ID: 29517594
[TBL] [Abstract][Full Text] [Related]
3. Socioeconomic Disparities in the Presentation and Treatment of Graves' Disease and Thyroid Eye Disease.
Vargason CW; Chelnis JG; Barahimi BI; Mawn LA
Semin Ophthalmol; 2016; 31(4):409-14. PubMed ID: 27385363
[TBL] [Abstract][Full Text] [Related]
4. Thyroid eye disease: therapy in the active phase.
Bhatti MT; Dutton JJ
J Neuroophthalmol; 2014 Jun; 34(2):186-97. PubMed ID: 24821102
[TBL] [Abstract][Full Text] [Related]
5. [LIFESTYLE ADJUSTMENT AS THERAPEUTIC TOOL IN THYROID EYE DISEASE].
Vashdi I; Gur Z
Harefuah; 2022 Apr; 161(4):223-227. PubMed ID: 35466606
[TBL] [Abstract][Full Text] [Related]
6. Reduced risk of compressive optic neuropathy using orbital radiotherapy in patients with active thyroid eye disease.
Shams PN; Ma R; Pickles T; Rootman J; Dolman PJ
Am J Ophthalmol; 2014 Jun; 157(6):1299-305. PubMed ID: 24582992
[TBL] [Abstract][Full Text] [Related]
7. Management of thyroid eye disease.
Bartalena L; Marcocci C; Tanda L; Pinchera A
Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S458-65. PubMed ID: 12192546
[TBL] [Abstract][Full Text] [Related]
8. Thyroid Eye Disease: Epidemiology, Natural History, and Risk Factors.
Bartalena L; Gallo D; Tanda ML; Kahaly GJ
Ophthalmic Plast Reconstr Surg; 2023 Dec; 39(6S):S2-S8. PubMed ID: 38054980
[TBL] [Abstract][Full Text] [Related]
9. Acute thyroid eye disease (TED): principles of medical and surgical management.
Verity DH; Rose GE
Eye (Lond); 2013 Mar; 27(3):308-19. PubMed ID: 23412559
[TBL] [Abstract][Full Text] [Related]
10. Knowledge of Thyroid Eye Disease in Graves' Disease Patients With and Without Orbitopathy.
Edmunds MR; Boelaert K
Thyroid; 2019 Apr; 29(4):557-562. PubMed ID: 30688164
[TBL] [Abstract][Full Text] [Related]
11. The Role of Biological Agents and Immunomodulators in Treatment Strategies for Thyroid Eye Disease: An Evidence-based Review.
Ginter A; Migliori ME
R I Med J (2013); 2016 Jun; 99(6):26-9. PubMed ID: 27247969
[TBL] [Abstract][Full Text] [Related]
12. Alemtuzumab-Induced Thyroid Eye Disease: A Comprehensive Case Series and Review of the Literature.
Nirmalan A; Blecher N; Hyder S; Couch SM; Godfrey KJ; Stan MN; Bradley EA; Wagner LH; Tooley AA
Ophthalmic Plast Reconstr Surg; 2023 Sep-Oct 01; 39(5):470-474. PubMed ID: 36893061
[TBL] [Abstract][Full Text] [Related]
13. Radiotherapy for Active Thyroid Eye Disease.
Godfrey KJ; Kazim M
Ophthalmic Plast Reconstr Surg; 2018; 34(4S Suppl 1):S98-S104. PubMed ID: 29771752
[TBL] [Abstract][Full Text] [Related]
14. Risk Factors of Thyroid Eye Disease.
Lee MH; Chin YH; Ng CH; Nistala KRY; Ow ZGW; Sundar G; Yang SP; Khoo CM
Endocr Pract; 2021 Mar; 27(3):245-253. PubMed ID: 33655885
[TBL] [Abstract][Full Text] [Related]
15. Dysthyroid optic neuropathy: update on pathogenesis, diagnosis, and management.
Blandford AD; Zhang D; Chundury RV; Perry JD
Expert Rev Ophthalmol; 2017; 12(2):111-121. PubMed ID: 28775762
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of Graves' disease in patients with thyroid eye disease].
Sviridenko NY; Sheremeta MS; Belovalova IM; Melnichenko GA
Vestn Oftalmol; 2021; 137(6):128-135. PubMed ID: 34965078
[TBL] [Abstract][Full Text] [Related]
17. Optic Nerve Head Vessel Density Changes from Graves' Disease without TED to TED Dysthyroid Optic Neuropathy: Does Optic Nerve Head Ischemia Play a Role?
Abdolalizadeh P; Kashkouli MB; Moradpasandi F; Falavarjani KG; Mirshahi R; Akbarian S
Ophthalmic Plast Reconstr Surg; 2022 May-Jun 01; 38(3):250-257. PubMed ID: 34593713
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and natural history of Graves' orbitopathy in the XXI century.
Piantanida E; Tanda ML; Lai A; Sassi L; Bartalena L
J Endocrinol Invest; 2013 Jun; 36(6):444-9. PubMed ID: 23587873
[TBL] [Abstract][Full Text] [Related]
19. An evidence-based approach to the treatment of Graves' ophthalmopathy.
Wiersinga WM; Prummel MF
Endocrinol Metab Clin North Am; 2000 Jun; 29(2):297-319, vi-vii. PubMed ID: 10874531
[TBL] [Abstract][Full Text] [Related]
20. Advances in the Treatment of Thyroid Eye Disease Associated Extraocular Muscle Myopathy and Optic Neuropathy.
Lu TJ; Amarikwa L; Sears CM; Kossler AL
Curr Neurol Neurosci Rep; 2022 Jun; 22(6):313-325. PubMed ID: 35614367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
